Thanks - I will take a look . On first pass looks good a the issue ofcourse is the huge capex relative to Market cap which means at some point a lot of dilution
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025